UVA School of Medicine emeritus professor Dr. Frederick G. Hayden helped design the trial and presented the results Wednesday ...

evaluating drug–drug interactions, establishing bioequivalence of generic compounds and pharmacogenetics. Burger's interest in the clinical pharmacology of antiviral and antimicrobial agents ...

An alternative to Paxlovid, the only antiviral pills approved by the US Food and Drug Administration to treat COVID-19, is on ...

Antiviral drugs can be used for the treatment of influenza and the prevention of seasonal and post-exposure influenza. Four antiviral drugs are available for the prevention and treatment of ...

What have been the guiding principles in these achievements and what might the future hold for antiviral drug development? In the late 1970s, the discovery that acyclic nucleoside analogues ...

An international clinical trial has identified a medication that can help prevent symptomatic COVID-19 in people exposed ...

Though we already have antivirals for COVID-19, in a situation like a pandemic, tools that help design antiviral drugs as efficiently as possible could save countless lives. Often, antivirals and ...

These might be amenable for the design of smaller drugs (peptidomimetics) that improve the pharmacology of BLV to prevent HBV and HDV binding and infection. The research was done in collaboration ...

THURSDAY, March 6, 2025 (HealthDay News) -- The antiviral drug Paxlovid may not offer much protection against COVID-related ...

“This is the first clinical trial of an oral antiviral drug to show significant protection against COVID-19,” said Hayden, part of the Division of Infectious Diseases and International Health ...